Alok Srivastava/LinkedIn, Khaled Musallam/LinkedIn
May 6, 2026, 02:23
Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“When the worlds of thalassemia and hemophilia converge, impactful advances are inevitable.
Delighted to welcome Prof Alok Srivastava as Visiting Professor, Consultant Hematologist, and Deputy Chief of Cell and Gene Therapy and Hematology at Burjeel Cancer Institute.
Excited for what lies ahead as we build robust services and bring forward innovative therapies for patients with blood disorders.”
More posts featuring Khaled Musallam on Hemostasis Today.
-
Jun 10, 2026, 04:20Ravindra Prasad Thokala: When T Cells Heal and Harm in the Same Transplant Unit
-
Jun 10, 2026, 04:15Jukka Partanen: How Blood Donation Selection Shapes the Human Genome Landscape
-
Jun 10, 2026, 04:02Heghine Khachatryan: What Should We Test From a Hematologic Perspective in Young Cryptogenic Stroke?
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease